Financial reports
ARS
2023 FY
Annual report to shareholders
18 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
18 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
27 Feb 24
8-K
Denali Therapeutics Announces $500 million Private Placement Equity Financing
27 Feb 24
8-K
Regulation FD Disclosure
16 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
7 Nov 23
8-K
Entry into a Material Definitive Agreement
21 Aug 23
8-K
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
8 Aug 23
8-K
Other Events
20 Jun 23
8-K
Other Events
5 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
Registration and prospectus
S-3ASR
Automatic shelf registration
22 Mar 24
D
$499.73 mm in equity / options, sold $499.73 mm, 11 investors
1 Mar 24
S-8
Registration of securities for employees
27 Feb 24
S-8
Registration of securities for employees
27 Feb 23
424B5
Prospectus supplement for primary offering
20 Oct 22
424B5
Prospectus supplement for primary offering
18 Oct 22
S-3ASR
Automatic shelf registration
28 Feb 22
S-8
Registration of securities for employees
28 Feb 22
S-8
Registration of securities for employees
26 Feb 21
S-8
Registration of securities for employees
28 Feb 20
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 23
DEF 14A
Definitive proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
19 Apr 22
DEF 14A
Definitive proxy
19 Apr 22
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
DEFA14A
Additional proxy soliciting materials
22 Apr 20
DEF 14A
Definitive proxy
22 Apr 20
Other
UPLOAD
Letter from SEC
7 Oct 19
CORRESP
Correspondence with SEC
11 Sep 19
UPLOAD
Letter from SEC
16 Aug 19
CORRESP
Correspondence with SEC
16 Jul 19
UPLOAD
Letter from SEC
2 Jul 19
CT ORDER
Confidential treatment order
25 Mar 19
CT ORDER
Confidential treatment order
21 Feb 19
CT ORDER
Confidential treatment order
19 Nov 18
CT ORDER
Confidential treatment order
17 Jul 18
CT ORDER
Confidential treatment order
8 Dec 17
Ownership
4
VICKI L SATO
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Steve E. Krognes
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Ryan J. Watts
29 Mar 24
4
VICKI L SATO
19 Mar 24
4
VICKI L SATO
20 Feb 24
4
Steve E. Krognes
15 Feb 24
4
Ryan J. Watts
15 Feb 24
4
Carole Ho
15 Feb 24